CYTOSORBENTS CORPORATION Diluted Shares Outstanding (Weighted Average)
CYTOSORBENTS CORPORATION (CTSO) reported Diluted Shares Outstanding (Weighted Average) of 62.81 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-06
- CYTOSORBENTS CORPORATION weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 62.81M shares, a 6.49% decline year-over-year.
- CYTOSORBENTS CORPORATION weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 62.74M shares, a 3.30% increase year-over-year.
- CYTOSORBENTS CORPORATION weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 62.81M shares, a 14.79% increase year-over-year.
- CYTOSORBENTS CORPORATION weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 62.75M shares, a 15.24% increase year-over-year.
- CYTOSORBENTS CORPORATION weighted average number of shares outstanding, diluted for fiscal 2025 was 62.23M shares, a 14.32% increase from fiscal 2024.
- CYTOSORBENTS CORPORATION weighted average number of shares outstanding, diluted for fiscal 2024 was 54.43M shares, a 21.90% increase from fiscal 2023.
- CYTOSORBENTS CORPORATION weighted average number of shares outstanding, diluted for fiscal 2023 was 44.66M shares, a 2.49% increase from fiscal 2022.
- CYTOSORBENTS CORPORATION weighted average number of shares outstanding, diluted for fiscal 2022 was 43.57M shares, a 0.49% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | 62.81M shares 10-Q · filed 2026-08-06 | 62.77M shares 10-Q · filed 2026-08-06 | 62.79M shares derived: average of 3 quarters · filed 2026-08-06 | 62.78M shares derived: average of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | 62.74M shares 10-Q · filed 2026-05-13 | 62.77M shares derived: average of 2 quarters · filed 2026-05-13 | 62.77M shares derived: average of 3 quarters · filed 2026-05-13 | 63.87M shares derived: average of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | 62.81M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 62.78M shares derived: average of 2 quarters · filed 2026-03-30 | 64.24M shares derived: average of 3 quarters · filed 2026-08-06 | 62.23M shares 10-K · filed 2026-03-30 | |
| 2025-09-30 | 62.75M shares 10-Q · filed 2025-11-13 | 64.96M shares derived: average of 2 quarters · filed 2026-08-06 | 62.04M shares 10-Q · filed 2025-11-13 | 61.34M shares derived: average of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | 67.17M shares 10-Q · filed 2026-08-06 | 66.26M shares 10-Q · filed 2026-08-06 | 60.87M shares derived: average of 3 quarters · filed 2026-08-06 | 59.27M shares derived: average of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | 60.73M shares 10-Q · filed 2026-05-13 | 57.72M shares derived: average of 2 quarters · filed 2026-05-13 | 56.63M shares derived: average of 3 quarters · filed 2026-05-13 | 56.05M shares derived: average of 4 quarters · filed 2026-05-13 | |
| 2024-12-31 | 54.72M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 54.58M shares derived: average of 2 quarters · filed 2026-03-30 | 54.49M shares derived: average of 3 quarters · filed 2026-03-30 | 54.43M shares 10-K · filed 2026-03-30 | |
| 2024-09-30 | 54.45M shares 10-Q · filed 2025-11-13 | 54.38M shares derived: average of 2 quarters · filed 2025-11-13 | 54.34M shares 10-Q · filed 2025-11-13 | 52.44M shares derived: average of 4 quarters · filed 2025-11-13 | |
| 2024-06-30 | 54.31M shares 10-Q · filed 2025-08-07 | 54.28M shares 10-Q · filed 2025-08-07 | 51.76M shares derived: average of 3 quarters · filed 2025-08-07 | 49.92M shares derived: average of 4 quarters · filed 2025-08-07 | |
| 2024-03-31 | 54.43M shares 10-Q · filed 2025-05-14 | 54.26M shares 10-Q · filed 2024-05-09 | 50.49M shares derived: average of 2 quarters · filed 2025-05-14 | 48.45M shares derived: average of 3 quarters · filed 2025-05-14 | 47.34M shares derived: average of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | 46.55M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 45.46M shares derived: average of 2 quarters · filed 2025-03-31 | 44.98M shares derived: average of 3 quarters · filed 2025-03-31 | 44.66M shares 10-K · filed 2025-03-31 | |
| 2023-09-30 | 44.37M shares 10-Q · filed 2024-11-07 | 44.19M shares derived: average of 2 quarters · filed 2024-11-07 | 44.02M shares 10-Q · filed 2024-11-07 | 43.93M shares derived: average of 4 quarters · filed 2024-11-07 | |
| 2023-06-30 | 44.02M shares 10-Q · filed 2024-08-13 | 43.76M shares 10-Q · filed 2024-08-13 | 43.78M shares derived: average of 3 quarters · filed 2024-08-13 | 43.73M shares derived: average of 4 quarters · filed 2024-08-13 | |
| 2023-03-31 | 43.68M shares 10-Q · filed 2024-05-09 | 43.66M shares derived: average of 2 quarters · filed 2024-05-09 | 43.64M shares derived: average of 3 quarters · filed 2024-05-09 | 43.62M shares derived: average of 4 quarters · filed 2024-05-09 | |
| 2022-12-31 | 43.64M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | 43.62M shares derived: average of 2 quarters · filed 2024-03-15 | 43.60M shares derived: average of 3 quarters · filed 2024-03-15 | 43.57M shares 10-K · filed 2024-03-15 | |
| 2022-09-30 | 43.61M shares 10-Q · filed 2023-11-09 | 43.58M shares derived: average of 2 quarters · filed 2023-11-09 | 43.55M shares 10-Q · filed 2023-11-09 | 43.53M shares derived: average of 4 quarters · filed 2024-03-15 | |
| 2022-06-30 | 43.56M shares 10-Q · filed 2023-08-01 | 43.52M shares 10-Q · filed 2023-08-01 | 43.51M shares derived: average of 3 quarters · filed 2024-03-15 | 43.48M shares derived: average of 4 quarters · filed 2024-03-15 | |
| 2022-03-31 | 43.49M shares 10-Q · filed 2023-05-02 | 41.59M shares 10-Q · filed 2022-05-03 | 43.48M shares derived: average of 2 quarters · filed 2024-03-15 | 43.45M shares derived: average of 3 quarters · filed 2024-03-15 | 43.42M shares derived: average of 4 quarters · filed 2024-03-15 |
| 2021-12-31 | 43.48M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | 43.44M shares derived: average of 2 quarters · filed 2024-03-15 | 43.40M shares derived: average of 3 quarters · filed 2024-03-15 | 43.36M shares 10-K · filed 2024-03-15 | |
| 2021-09-30 | 43.40M shares 10-Q · filed 2022-11-03 | 43.36M shares derived: average of 2 quarters · filed 2022-11-03 | 43.32M shares 10-Q · filed 2022-11-03 | 43.31M shares derived: average of 4 quarters · filed 2023-03-09 | |
| 2021-06-30 | 43.32M shares 10-Q · filed 2022-08-02 | 43.28M shares 10-Q · filed 2022-08-02 | 43.29M shares derived: average of 3 quarters · filed 2023-03-09 | 42.86M shares derived: average of 4 quarters · filed 2023-03-09 | |
| 2021-03-31 | 43.32M shares 10-Q · filed 2022-05-03 | 43.27M shares derived: average of 2 quarters · filed 2023-03-09 | 42.71M shares derived: average of 3 quarters · filed 2023-03-09 | ||
| 2020-12-31 | 43.22M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | 42.41M shares derived: average of 2 quarters · filed 2023-03-09 | 38.82M shares 10-K · filed 2023-03-09 | ||
| 2020-09-30 | 41.59M shares 10-Q · filed 2021-11-04 | 37.35M shares 10-Q · filed 2021-11-04 | |||
| 2019-12-31 | 32.26M shares 10-K · filed 2022-03-10 | ||||
| 2016-06-30 | 25.42M shares 10-Q · filed 2016-08-09 | 25.41M shares 10-Q · filed 2016-08-09 | |||
| 2015-06-30 | 28.83M shares 10-Q · filed 2016-08-09 | 24.58M shares 10-Q · filed 2016-08-09 | |||
| 2014-06-30 | 12.05M shares 10-Q · filed 2015-08-13 | 11.34M shares 10-Q · filed 2015-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |